Dat Ngo

476 total citations
28 papers, 221 citations indexed

About

Dat Ngo is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Dat Ngo has authored 28 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Oncology. Recurrent topics in Dat Ngo's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Dat Ngo is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Dat Ngo collaborates with scholars based in United States, Vietnam and Cambodia. Dat Ngo's co-authors include Vinod Pullarkat, Ibrahim Aldoss, Monzr M. Al Malki, Ahmed Aribi, Haris Ali, Ryotaro Nakamura, Guido Marcucci, Stephen J. Forman, Shukaib Arslan and Binh T. Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and RSC Advances.

In The Last Decade

Dat Ngo

25 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dat Ngo United States 9 74 61 54 40 36 28 221
Priti Tewari United States 8 74 1.0× 117 1.9× 38 0.7× 15 0.4× 65 1.8× 47 235
Kathy R. Hogan United States 8 230 3.1× 124 2.0× 50 0.9× 15 0.4× 33 0.9× 9 334
Dunia de Miguel Spain 8 77 1.0× 118 1.9× 25 0.5× 37 0.9× 6 0.2× 18 268
Najla El Jurdi United States 9 119 1.6× 78 1.3× 22 0.4× 28 0.7× 35 1.0× 50 246
Marie Y. Detrait France 8 116 1.6× 114 1.9× 14 0.3× 39 1.0× 65 1.8× 25 333
Chiara Ghiggi Italy 8 87 1.2× 65 1.1× 45 0.8× 134 3.4× 15 0.4× 24 318
Gabrielle Roth-Guépin France 8 109 1.5× 97 1.6× 31 0.6× 16 0.4× 29 0.8× 14 177
Elisabetta Xue Italy 9 71 1.0× 63 1.0× 34 0.6× 14 0.3× 32 0.9× 31 228
Célestine Simand France 8 82 1.1× 58 1.0× 75 1.4× 72 1.8× 25 0.7× 20 223
Caroline Wehmeier Switzerland 13 26 0.4× 110 1.8× 76 1.4× 42 1.1× 73 2.0× 31 455

Countries citing papers authored by Dat Ngo

Since Specialization
Citations

This map shows the geographic impact of Dat Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dat Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dat Ngo more than expected).

Fields of papers citing papers by Dat Ngo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dat Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dat Ngo. The network helps show where Dat Ngo may publish in the future.

Co-authorship network of co-authors of Dat Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Dat Ngo. A scholar is included among the top collaborators of Dat Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dat Ngo. Dat Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phạm, Quốc Thắng, et al.. (2025). CAAF-ResUNet: Adaptive Attention Fusion with Boundary-Aware Loss for Lung Nodule Segmentation. Medicina. 61(7). 1126–1126. 3 indexed citations
2.
Nguyễn, Kim, Dat Ngo, Vaibhav Agrawal, et al.. (2025). The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ ALL With High Disease Burden. American Journal of Hematology. 100(12). 2209–2219.
3.
Ngo, Dat, Shanpeng Li, Joycelynne Palmer, et al.. (2024). Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leukemia & lymphoma. 65(3). 372–377. 2 indexed citations
4.
Ngo, Dat, et al.. (2024). Glofitamab in patients with HIV-associated B-cell lymphoma. Leukemia & lymphoma. 66(5). 969–972.
5.
Ngo, Dat, Joo Y. Song, Huiyan Ma, et al.. (2024). The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia. Leukemia & lymphoma. 65(13). 2016–2024.
6.
Ngo, Dat, et al.. (2024). Patterns of interventions for central venous catheter-associated deep vein thrombosis and outcomes in cancer patients. Journal of Oncology Pharmacy Practice. 31(1). 12–16. 2 indexed citations
7.
8.
9.
10.
11.
Lee, Brian, Dat Ngo, Jason Chen, et al.. (2022). AML-491 Real World Practice of FLAG-Idarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience. Clinical Lymphoma Myeloma & Leukemia. 22. S256–S257. 1 indexed citations
12.
Ali, Haris, Dat Ngo, Ahmed Aribi, et al.. (2021). Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 27(11). 938.e1–938.e6. 40 indexed citations
13.
Salhotra, Amandeep, Ahmed Aribi, Dat Ngo, et al.. (2021). Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351). American Journal of Hematology. 96(6). E196–E200. 8 indexed citations
14.
Aldoss, Ibrahim, Jianying Zhang, Matthew Mei, et al.. (2020). Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia. American Journal of Hematology. 95(10). 1193–1199. 27 indexed citations
15.
Ngo, Dat, et al.. (2020). Thermodynamics of selective serotonin reuptake inhibitors partitioning into 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayers. RSC Advances. 10(64). 39338–39347. 2 indexed citations
16.
17.
Ngo, Dat, et al.. (2020). Levocarnitine for pegasparaginase-induced hepatotoxicity in acute lymphoblastic leukemia. Leukemia & lymphoma. 61(13). 3161–3164. 9 indexed citations
18.
Ngo, Dat, et al.. (2020). A Clinical Review of Biosimilars Approved in Oncology. Annals of Pharmacotherapy. 55(3). 362–377. 6 indexed citations
19.
20.
Patel, Samit, Michaela Liedtke, Dat Ngo, & Bruno C. Medeiros. (2013). A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia. Leukemia & lymphoma. 54(10). 2231–2235. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priti Tewari Breakdown of academic impact, for papers by Kathy R. Hogan Breakdown of academic impact, for papers by Dunia de Miguel Breakdown of academic impact, for papers by Najla El Jurdi Breakdown of academic impact, for papers by Marie Y. Detrait Breakdown of academic impact, for papers by Chiara Ghiggi Breakdown of academic impact, for papers by Gabrielle Roth-Guépin Breakdown of academic impact, for papers by Elisabetta Xue Breakdown of academic impact, for papers by Célestine Simand Breakdown of academic impact, for papers by Caroline Wehmeier
Rankless by CCL
2026